Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

A Rare Case of Left Subacute Atrial Dissection: Multimodality Imaging Approach.

Lavorgna A, Villani C, Fabiani D, Napoletano C.

J Cardiovasc Echogr. 2019 Jan-Mar;29(1):26-28. doi: 10.4103/jcecho.jcecho_52_18.

2.

Bevacizumab-Based Chemotherapy Triggers Immunological Effects in Responding Multi-Treated Recurrent Ovarian Cancer Patients by Favoring the Recruitment of Effector T Cell Subsets.

Napoletano C, Ruscito I, Bellati F, Zizzari IG, Rahimi H, Gasparri ML, Antonilli M, Panici PB, Rughetti A, Nuti M.

J Clin Med. 2019 Mar 18;8(3). pii: E380. doi: 10.3390/jcm8030380.

3.

The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinoma.

Di Matteo S, Nevi L, Costantini D, Overi D, Carpino G, Safarikia S, Giulitti F, Napoletano C, Manzi E, De Rose AM, Melandro F, Bragazzi M, Berloco PB, Giuliante F, Grazi G, Giorgi A, Cardinale V, Adorini L, Gaudio E, Alvaro D.

PLoS One. 2019 Jan 24;14(1):e0210077. doi: 10.1371/journal.pone.0210077. eCollection 2019.

4.

Clozapine-related Sudden Pericarditis in a Patient Taking Long Acting Aripiprazole and Valproate: A Case Report.

De Berardis D, Fornaro M, Orsolini L, Olivieri L, Nappi F, Rapini G, Vellante F, Napoletano C, Serroni N, Giannantonio MD.

Clin Psychopharmacol Neurosci. 2018 Nov 30;16(4):505-507. doi: 10.9758/cpn.2018.16.4.505.

5.

Tumor-Derived Microvesicles Enhance Cross-Processing Ability of Clinical Grade Dendritic Cells.

Dionisi M, De Archangelis C, Battisti F, Rahimi Koshkaki H, Belleudi F, Zizzari IG, Ruscito I, Albano C, Di Filippo A, Torrisi MR, Benedetti Panici P, Napoletano C, Nuti M, Rughetti A.

Front Immunol. 2018 Nov 5;9:2481. doi: 10.3389/fimmu.2018.02481. eCollection 2018.

6.

The prognostic impact of cancer stem-like cell biomarker aldehyde dehydrogenase-1 (ALDH1) in ovarian cancer: A meta-analysis.

Ruscito I, Darb-Esfahani S, Kulbe H, Bellati F, Zizzari IG, Rahimi Koshkaki H, Napoletano C, Caserta D, Rughetti A, Kessler M, Sehouli J, Nuti M, Braicu EI.

Gynecol Oncol. 2018 Jul;150(1):151-157. doi: 10.1016/j.ygyno.2018.05.006. Epub 2018 May 10.

PMID:
29753392
7.

TK Inhibitor Pazopanib Primes DCs by Downregulation of the β-Catenin Pathway.

Zizzari IG, Napoletano C, Botticelli A, Caponnetto S, Calabrò F, Gelibter A, Rughetti A, Ruscito I, Rahimi H, Rossi E, Schinzari G, Marchetti P, Nuti M.

Cancer Immunol Res. 2018 Jun;6(6):711-722. doi: 10.1158/2326-6066.CIR-17-0594. Epub 2018 Apr 26.

8.

Anisakis pegreffii impacts differentiation and function of human dendritic cells.

Napoletano C, Mattiucci S, Colantoni A, Battisti F, Zizzari IG, Rahimi H, Nuti M, Rughetti A.

Parasite Immunol. 2018 May;40(5):e12527. doi: 10.1111/pim.12527.

9.

The sexist behaviour of immune checkpoint inhibitors in cancer therapy?

Botticelli A, Onesti CE, Zizzari I, Cerbelli B, Sciattella P, Occhipinti M, Roberto M, Di Pietro F, Bonifacino A, Ghidini M, Vici P, Pizzuti L, Napoletano C, Strigari L, D'Amati G, Mazzuca F, Nuti M, Marchetti P.

Oncotarget. 2017 Nov 1;8(59):99336-99346. doi: 10.18632/oncotarget.22242. eCollection 2017 Nov 21.

10.

Tumor-Derived Microvesicles Modulate Antigen Cross-Processing via Reactive Oxygen Species-Mediated Alkalinization of Phagosomal Compartment in Dendritic Cells.

Battisti F, Napoletano C, Rahimi Koshkaki H, Belleudi F, Zizzari IG, Ruscito I, Palchetti S, Bellati F, Benedetti Panici P, Torrisi MR, Caracciolo G, Altieri F, Nuti M, Rughetti A.

Front Immunol. 2017 Sep 25;8:1179. doi: 10.3389/fimmu.2017.01179. eCollection 2017.

11.

TGF-β signaling is an effective target to impair survival and induce apoptosis of human cholangiocarcinoma cells: A study on human primary cell cultures.

Lustri AM, Di Matteo S, Fraveto A, Costantini D, Cantafora A, Napoletano C, Bragazzi MC, Giuliante F, De Rose AM, Berloco PB, Grazi GL, Carpino G, Alvaro D.

PLoS One. 2017 Sep 5;12(9):e0183932. doi: 10.1371/journal.pone.0183932. eCollection 2017.

12.

Cross-talk between microbiota and immune fitness to steer and control response to anti PD-1/PDL-1 treatment.

Botticelli A, Zizzari I, Mazzuca F, Ascierto PA, Putignani L, Marchetti L, Napoletano C, Nuti M, Marchetti P.

Oncotarget. 2017 Jan 31;8(5):8890-8899. doi: 10.18632/oncotarget.12985. Review.

13.

Immunological and Clinical Impact of Cancer Stem Cells in Vulvar Cancer: Role of CD133/CD24/ABCG2-Expressing Cells.

Napoletano C, Bellati F, Ruscito I, Pernice M, Zizzari IG, Caponnetto S, Tomao F, Frigerio L, Liberati M, Rughetti A, Caserta D, Panici PB, Nuti M.

Anticancer Res. 2016 Oct;36(10):5109-5116.

PMID:
27798870
14.

Triple peptide vaccination as consolidation treatment in women affected by ovarian and breast cancer: Clinical and immunological data of a phase I/II clinical trial.

Antonilli M, Rahimi H, Visconti V, Napoletano C, Ruscito I, Zizzari IG, Caponnetto S, Barchiesi G, Iadarola R, Pierelli L, Rughetti A, Bellati F, Panici PB, Nuti M.

Int J Oncol. 2016 Apr;48(4):1369-78. doi: 10.3892/ijo.2016.3386. Epub 2016 Feb 8.

15.

MGL Receptor and Immunity: When the Ligand Can Make the Difference.

Zizzari IG, Napoletano C, Battisti F, Rahimi H, Caponnetto S, Pierelli L, Nuti M, Rughetti A.

J Immunol Res. 2015;2015:450695. doi: 10.1155/2015/450695. Epub 2015 Dec 29. Review.

16.

Sensitivity of Human Intrahepatic Cholangiocarcinoma Subtypes to Chemotherapeutics and Molecular Targeted Agents: A Study on Primary Cell Cultures.

Fraveto A, Cardinale V, Bragazzi MC, Giuliante F, De Rose AM, Grazi GL, Napoletano C, Semeraro R, Lustri AM, Costantini D, Nevi L, Di Matteo S, Renzi A, Carpino G, Gaudio E, Alvaro D.

PLoS One. 2015 Nov 16;10(11):e0142124. doi: 10.1371/journal.pone.0142124. eCollection 2015.

17.

Cardiosphere conditioned media influence the plasticity of human mediastinal adipose tissue-derived mesenchymal stem cells.

Siciliano C, Chimenti I, Ibrahim M, Napoletano C, Mangino G, Scafetta G, Zoccai GB, Rendina EA, Calogero A, Frati G, De Falco E.

Cell Transplant. 2015;24(11):2307-22. doi: 10.3727/096368914X685771.

PMID:
26531290
18.

The Macrophage Galactose-Type C-Type Lectin (MGL) Modulates Regulatory T Cell Functions.

Zizzari IG, Martufi P, Battisti F, Rahimi H, Caponnetto S, Bellati F, Nuti M, Rughetti A, Napoletano C.

PLoS One. 2015 Jul 6;10(7):e0132617. doi: 10.1371/journal.pone.0132617. eCollection 2015.

19.

Profiles of cancer stem cell subpopulations in cholangiocarcinomas.

Cardinale V, Renzi A, Carpino G, Torrice A, Bragazzi MC, Giuliante F, DeRose AM, Fraveto A, Onori P, Napoletano C, Franchitto A, Cantafora A, Grazi G, Caporaso N, D'Argenio G, Alpini G, Reid LM, Gaudio E, Alvaro D.

Am J Pathol. 2015 Jun;185(6):1724-39. doi: 10.1016/j.ajpath.2015.02.010. Epub 2015 Apr 17.

20.

Transplantation of human fetal biliary tree stem/progenitor cells into two patients with advanced liver cirrhosis.

Cardinale V, Carpino G, Gentile R, Napoletano C, Rahimi H, Franchitto A, Semeraro R, Nuti M, Onori P, Berloco PB, Rossi M, Bosco D, Brunelli R, Fraveto A, Napoli C, Torrice A, Gatto M, Venere R, Bastianelli C, Aliberti C, Salvatori FM, Bresadola L, Bezzi M, Attili AF, Reid L, Gaudio E, Alvaro D.

BMC Gastroenterol. 2014 Dec 4;14:204. doi: 10.1186/s12876-014-0204-z.

21.

Clozapine-related pericarditis during titration phase in a patient with resistant schizophrenia and concomitant valproate treatment: a case report.

De Berardis D, Campanella D, Serroni N, Rapini G, Olivieri L, Fornaro M, Valchera A, Iasevoli F, Napoletano C, Martinotti G, Giannantonio MD.

J Clin Psychopharmacol. 2014 Oct;34(5):649-51. doi: 10.1097/JCP.0000000000000179. No abstract available.

PMID:
25006818
22.

The Fas/Fas ligand apoptosis pathway underlies immunomodulatory properties of human biliary tree stem/progenitor cells.

Riccio M, Carnevale G, Cardinale V, Gibellini L, De Biasi S, Pisciotta A, Carpino G, Gentile R, Berloco PB, Brunelli R, Bastianelli C, Napoletano C, Cantafora A, Cossarizza A, Gaudio E, Alvaro D, De Pol A.

J Hepatol. 2014 Nov;61(5):1097-105. doi: 10.1016/j.jhep.2014.06.016. Epub 2014 Jun 19.

PMID:
24953023
23.

Microvesicle cargo of tumor-associated MUC1 to dendritic cells allows cross-presentation and specific carbohydrate processing.

Rughetti A, Rahimi H, Belleudi F, Napoletano C, Battisti F, Zizzari IG, Antonilli M, Bellati F, Wandall HH, Benedetti Panici P, Burchell JM, Torrisi MR, Nuti M.

Cancer Immunol Res. 2014 Feb;2(2):177-86. doi: 10.1158/2326-6066.CIR-13-0112-T. Epub 2013 Oct 28.

24.

Evidence for multipotent endodermal stem/progenitor cell populations in human gallbladder.

Carpino G, Cardinale V, Gentile R, Onori P, Semeraro R, Franchitto A, Wang Y, Bosco D, Iossa A, Napoletano C, Cantafora A, D'Argenio G, Nuti M, Caporaso N, Berloco P, Venere R, Oikawa T, Reid L, Alvaro D, Gaudio E.

J Hepatol. 2014 Jun;60(6):1194-202. doi: 10.1016/j.jhep.2014.01.026. Epub 2014 Feb 13.

PMID:
24530598
25.

Optimization of the isolation and expansion method of human mediastinal-adipose tissue derived mesenchymal stem cells with virally inactivated GMP-grade platelet lysate.

Siciliano C, Ibrahim M, Scafetta G, Napoletano C, Mangino G, Pierelli L, Frati G, De Falco E.

Cytotechnology. 2015 Jan;67(1):165-74. doi: 10.1007/s10616-013-9667-y. Epub 2013 Dec 4.

26.

Discovery of chemotherapy-associated ovarian cancer antigens by interrogating memory T cells.

Paroli M, Bellati F, Videtta M, Focaccetti C, Mancone C, Donato T, Antonilli M, Perniola G, Accapezzato D, Napoletano C, Nuti M, Bartolazzi A, Panici PB, Tripodi M, Palombo F, Barnaba V.

Int J Cancer. 2014 Apr 15;134(8):1823-34. doi: 10.1002/ijc.28515. Epub 2013 Oct 22. Erratum in: Int J Cancer. 2014 Jul 15;135(2):E1.

27.

[Critical issues in megatrials on new oral anticoagulants. Rocket AF: applying results to low risk patients].

Uguccioni M, Napoletano C.

Monaldi Arch Chest Dis. 2013 Mar;80(1):3-6. Review. Italian. No abstract available.

28.

Suitability of human Tenon's fibroblasts as feeder cells for culturing human limbal epithelial stem cells.

Scafetta G, Tricoli E, Siciliano C, Napoletano C, Puca R, Vingolo EM, Cavallaro G, Polistena A, Frati G, De Falco E.

Stem Cell Rev Rep. 2013 Dec;9(6):847-57. doi: 10.1007/s12015-013-9451-6.

PMID:
23832306
29.

Interaction between Treg cells and angiogenesis: a dark double track.

Gasparri ML, Bellati F, Napoletano C, Panici PB, Nuti M.

Int J Cancer. 2013 May 15;132(10):2469. doi: 10.1002/ijc.27920. Epub 2012 Nov 20. No abstract available.

30.

Past, present and future strategies of immunotherapy in gynecological malignancies.

Bellati F, Napoletano C, Ruscito I, Visconti V, Antonilli M, Gasparri ML, Zizzari IG, Rahimi H, Palaia I, Rughetti A, Benedetti Panici P, Nuti M.

Curr Mol Med. 2013 May;13(4):648-69.

PMID:
22934850
31.

A standardized laboratory and surgical method for in vitro culture isolation and expansion of primary human Tenon's fibroblasts.

De Falco E, Scafetta G, Napoletano C, Puca R, Vingolo EM, Ragona G, Iorio O, Frati G.

Cell Tissue Bank. 2013 Jun;14(2):277-87. doi: 10.1007/s10561-012-9325-1. Epub 2012 Jul 21.

PMID:
22820760
32.

Targeting of macrophage galactose-type C-type lectin (MGL) induces DC signaling and activation.

Napoletano C, Zizzari IG, Rughetti A, Rahimi H, Irimura T, Clausen H, Wandall HH, Belleudi F, Bellati F, Pierelli L, Frati L, Nuti M.

Eur J Immunol. 2012 Apr;42(4):936-45. doi: 10.1002/eji.201142086.

33.

Monoclonal antibodies in gynecological cancer: a critical point of view.

Bellati F, Napoletano C, Gasparri ML, Visconti V, Zizzari IG, Ruscito I, Caccetta J, Rughetti A, Benedetti-Panici P, Nuti M.

Clin Dev Immunol. 2011;2011:890758. doi: 10.1155/2011/890758. Epub 2011 Dec 26. Review.

34.

Current knowledge and open issues regarding bevacizumab in gynaecological neoplasms.

Bellati F, Napoletano C, Gasparri ML, Ruscito I, Marchetti C, Pignata S, Tomao F, Benedetti Panici P, Nuti M.

Crit Rev Oncol Hematol. 2012 Jul;83(1):35-46. doi: 10.1016/j.critrevonc.2011.09.006. Epub 2011 Nov 4. Review.

PMID:
22056314
35.

Thinking twice before abandoning first-line chemotherapy in ovarian cancer: report of two cases and literature review. Passing from tri-weekly to weekly regimens.

Marchetti C, Bellati F, Musella A, Napoletano C, Perniola G, Di Donato V, Pignata S, Nuti M, Panici PB.

Int J Clin Oncol. 2012 Aug;17(4):385-9. doi: 10.1007/s10147-011-0300-9. Epub 2011 Sep 3.

PMID:
21892670
36.

HER2-based recombinant immunogen to target DCs through FcγRs for cancer immunotherapy.

Zizzari IG, Veglia F, Taurino F, Rahimi H, Quaglino E, Belleudi F, Riccardo F, Antonilli M, Napoletano C, Bellati F, Benedetti-Panici P, Torrisi MR, Frati L, Nuti M, Rughetti A.

J Mol Med (Berl). 2011 Dec;89(12):1231-40. doi: 10.1007/s00109-011-0794-7. Epub 2011 Aug 16.

37.

Immune effects of trastuzumab.

Nuti M, Bellati F, Visconti V, Napoletano C, Domenici L, Caccetta J, Zizzari IG, Ruscito I, Rahimi H, Benedetti-Panici P, Rughetti A.

J Cancer. 2011;2:317-23. Epub 2011 May 25.

38.

Immunologic systemic effect of neoadjuvant chemotherapy requires investigation before tumor-associated lymphocytes can be introduced in breast cancer treatment algorithm.

Bellati F, Napoletano C, Gasparri ML, Panici PB, Nuti M.

J Clin Oncol. 2010 Sep 20;28(27):e471-2; author reply e473. doi: 10.1200/JCO.2010.27.9984. Epub 2010 Jun 28. No abstract available.

PMID:
20585098
39.

Cellular adaptive immune system plays a crucial role in trastuzumab clinical efficacy.

Bellati F, Napoletano C, Ruscito I, Liberati M, Panici PB, Nuti M.

J Clin Oncol. 2010 Jul 20;28(21):e369-70; author reply e371. doi: 10.1200/JCO.2010.28.6922. Epub 2010 May 17. No abstract available.

PMID:
20479394
40.

Complete remission of ovarian cancer induced intractable malignant ascites with intraperitoneal bevacizumab. Immunological observations and a literature review.

Bellati F, Napoletano C, Ruscito I, Pastore M, Pernice M, Antonilli M, Nuti M, Benedetti Panici P.

Invest New Drugs. 2010 Dec;28(6):887-94. doi: 10.1007/s10637-009-9351-4. Epub 2009 Nov 24. Review.

PMID:
19936983
41.

Osteoporosis: recent physiopatologic acquisitions and new therapeutic perspectives.

Cesareo R, Napoletano C, Iozzino M, De Rosa B, Iarussi G, Scona M, Romitelli F.

Minerva Endocrinol. 2009 Sep;34(3):255-62. Review.

PMID:
19859047
42.

Immunogenicity of allo-vesicle carrying ERBB2 tumor antigen for dendritic cell-based anti-tumor immunotherapy.

Napoletano C, Rughetti A, Landi R, Pinto D, Bellati F, Rahimi H, Spinelli GP, Pauselli S, Sale P, Dolo V, De Lorenzo F, Tomao F, Benedetti-Panici P, Frati L, Nuti M.

Int J Immunopathol Pharmacol. 2009 Jul-Sep;22(3):647-58.

PMID:
19822081
43.

Ovarian cancer cytoreduction induces changes in T cell population subsets reducing immunosuppression.

Napoletano C, Bellati F, Landi R, Pauselli S, Marchetti C, Visconti V, Sale P, Liberati M, Rughetti A, Frati L, Panici PB, Nuti M.

J Cell Mol Med. 2010 Dec;14(12):2748-59. doi: 10.1111/j.1582-4934.2009.00911.x.

44.

HPV induced triple neoplasms: a case report.

Visconti V, Antonilli M, Bellati F, Napoletano C, French D, Benedetti Panici P, Nuti M.

Am J Obstet Gynecol. 2009 Aug;201(2):e9-e12. doi: 10.1016/j.ajog.2009.05.008.

PMID:
19646562
45.

Immunology of gynecologic neoplasms: analysis of the prognostic significance of the immune status.

Bellati F, Visconti V, Napoletano C, Antonilli M, Frati L, Panici PB, Nuti M.

Curr Cancer Drug Targets. 2009 Jun;9(4):541-65. Review.

PMID:
19519321
46.

Cells with characteristics of cancer stem/progenitor cells express the CD133 antigen in human endometrial tumors.

Rutella S, Bonanno G, Procoli A, Mariotti A, Corallo M, Prisco MG, Eramo A, Napoletano C, Gallo D, Perillo A, Nuti M, Pierelli L, Testa U, Scambia G, Ferrandina G.

Clin Cancer Res. 2009 Jul 1;15(13):4299-311. doi: 10.1158/1078-0432.CCR-08-1883. Epub 2009 Jun 9.

47.

Death from metastatic donor-derived ovarian cancer in a male kidney transplant recipient.

Bellati F, Napoletano C, Nuti M, Benedetti Panici P.

Am J Transplant. 2009 May;9(5):1253. doi: 10.1111/j.1600-6143.2009.02601.x. No abstract available.

48.

RFA strongly modulates the immune system and anti-tumor immune responses in metastatic liver patients.

Napoletano C, Taurino F, Biffoni M, De Majo A, Coscarella G, Bellati F, Rahimi H, Pauselli S, Pellicciotta I, Burchell JM, Gaspari LA, Ercoli L, Rossi P, Rughetti A.

Int J Oncol. 2008 Feb;32(2):481-90.

PMID:
18202772
49.

MAGE-A and NY-ESO-1 expression in cervical cancer: prognostic factors and effects of chemotherapy.

Napoletano C, Bellati F, Tarquini E, Tomao F, Taurino F, Spagnoli G, Rughetti A, Muzii L, Nuti M, Benedetti Panici P.

Am J Obstet Gynecol. 2008 Jan;198(1):99.e1-7. doi: 10.1016/j.ajog.2007.05.019.

PMID:
18166319
50.

Cancer testis antigen expression in primary and recurrent vulvar cancer: association with prognostic factors.

Bellati F, Napoletano C, Tarquini E, Palaia I, Landi R, Manci N, Spagnoli G, Rughetti A, Panici PB, Nuti M.

Eur J Cancer. 2007 Nov;43(17):2621-7. Epub 2007 Oct 22.

PMID:
17950595

Supplemental Content

Loading ...
Support Center